Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

10.42 +0.22 (+2.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 177,497
Open 10.25
Bid (Size) 10.42 (1)
Ask (Size) 10.44 (1)
Prev. Close 10.20
Today's Range 10.04 - 10.56
52wk Range 6.920 - 16.64
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire

Performance

YTD
-25.78%
-25.78%
1 Month
-8.76%
-8.76%
3 Month
-25.73%
-25.73%
6 Month
+29.28%
+29.28%
1 Year
-30.44%
-30.44%

More News

Read More
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
From OptimizeRx Corporation
Via GlobeNewswire
Where OptimizeRx Stands With Analysts
Via Benzinga
7 Top Undervalued Stocks Primed for a Multibagger Recovery
Via InvestorPlace
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 28, 2024
Via Benzinga
OptimizeRx Earnings Preview
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
A Preview Of OptimizeRx's Earnings
Via Benzinga
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
OptimizeRx Reports Third Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Digital Health Tech OptimizeRx's Acquisition of Medicx Health To Boost Earnings And Market Potential: Analyst
Via Benzinga
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
From OptimizeRx Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.